Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Settleman

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Cancer & Metabolism|November 8, 2014
Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cellsYuting Sun, Anneleen Daemen, Georgia Hatzivassiliou, et al.
Cancer Cell|April 8, 2016
mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer CellsRaju V Pusapati, Anneleen Daemen, Catherine Wilson, et al.
Nature|May 20, 2016
Reproducible pharmacogenomic profiling of cancer cell line panelsPeter M Haverty, Eva Lin, Jenille Tan, et al.
Cell Metabolism|September 13, 2016
Proline Starvation Induces Unresolved ER Stress and Hinders mTORC1-Dependent TumorigenesisNisebita Sahu, Darlene Dela Cruz, Min Gao, et al.
Cancer Research|August 16, 2014
AXL inhibition sensitizes mesenchymal cancer cells to antimitotic drugsCatherine Wilson, Xiaofen Ye, Thinh Pham, et al.
Disease Models & Mechanisms|February 10, 2010
Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapyCristina M Contreras, Esra A Akbay, Teresa D Gallardo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Targeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastropheFabrizio Galimberti, Sarah L Thompson, Xi Liu, et al.
Nature Genetics|November 1, 2005
Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFRDaphne W Bell, Ira Gore, Ross A Okimoto, et al.
Cancer Research|March 21, 2014
EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiationMeng Wang, Ashley M Kern, Marieke Hülskötter, et al.
Molecular Cancer Research : MCR|February 11, 2015
Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkersQi Liu, Meng Wang, Ashley M Kern, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Cancer & Metabolism|November 8, 2014
Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cellsYuting Sun, Anneleen Daemen, Georgia Hatzivassiliou, et al.
Cancer Cell|April 8, 2016
mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer CellsRaju V Pusapati, Anneleen Daemen, Catherine Wilson, et al.
Nature|May 20, 2016
Reproducible pharmacogenomic profiling of cancer cell line panelsPeter M Haverty, Eva Lin, Jenille Tan, et al.
Cell Metabolism|September 13, 2016
Proline Starvation Induces Unresolved ER Stress and Hinders mTORC1-Dependent TumorigenesisNisebita Sahu, Darlene Dela Cruz, Min Gao, et al.
Cancer Research|August 16, 2014
AXL inhibition sensitizes mesenchymal cancer cells to antimitotic drugsCatherine Wilson, Xiaofen Ye, Thinh Pham, et al.
Disease Models & Mechanisms|February 10, 2010
Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapyCristina M Contreras, Esra A Akbay, Teresa D Gallardo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Targeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastropheFabrizio Galimberti, Sarah L Thompson, Xi Liu, et al.
Nature Genetics|November 1, 2005
Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFRDaphne W Bell, Ira Gore, Ross A Okimoto, et al.
Cancer Research|March 21, 2014
EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiationMeng Wang, Ashley M Kern, Marieke Hülskötter, et al.
Molecular Cancer Research : MCR|February 11, 2015
Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkersQi Liu, Meng Wang, Ashley M Kern, et al.
Pageof 7